Home > Insider Trading > Filing (0001610618-21-000031)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1610618	Cidara Therapeutics Inc.	CDTX	Biological Products, (No Disgnostic Substances) (2836)	461537286

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1639144	Paul Daruwala	C/O Cidara Therapeutics, Inc. 6310 Nancy Ridge Drive, Ste 101 San Diego CA 92121	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-01-05	2,868	$2.06	49,724	No	4	S	Direct
Common Stock	Acquisiton	2021-03-31	1,400	$0.00	51,124	No	4	A	Direct
Common Stock	Disposition	2021-04-01	593	$2.66	50,531	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	A	Direct
No	4	S	Direct

Footnotes

Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs on 1/1/21. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
The reporting person was previously granted a performance restricted stock unit (PRSU) to vest upon the achievement of a certain milestone event that occurred on 3/31/21.
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs on 03/31/21. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.